Lista de obras - Anne Tailleux - Dominio Público Uruguay

A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice

artículo científico publicado en 1995

Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty

artículo científico publicado en 2000

Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production

artículo científico publicado en 2012

Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase

artículo científico publicado en 2017

Apolipoprotein A-II, HDL metabolism and atherosclerosis

artículo científico publicado en 2002

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

artículo científico publicado en 2022

Bariatric surgery, lipoprotein metabolism and cardiovascular risk

artículo científico

Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects

artículo científico publicado en 2017

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2017

Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development

artículo científico publicado en 2012

Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1α pathway

artículo científico publicado en 2014

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

artículo científico publicado en 2012

Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for R

artículo científico publicado en 1997

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

artículo científico publicado en 2015

Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta

artículo científico publicado en 2002

Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

artículo científico publicado en 2000

Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.

artículo científico publicado en 2012

Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation

artículo científico publicado en 2013

Endothelial Derived Vasorelaxation Is Impaired in Human APO A-I Transgenic Rabbits

artículo científico publicado en 1997

Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients

scientific article published on 01 December 1993

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

artículo científico publicado en 2015

Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).

artículo científico publicado en 2014

HDL heterogeneity and atherosclerosis.

artículo científico publicado en 1996

Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly.

artículo científico publicado en 2013

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

artículo científico publicado en 2013

Host glucose metabolism mediates T4 and IL-7 action on Schistosoma mansoni development.

artículo científico publicado en 2005

Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.

artículo científico publicado en 2011

Immunological and functional properties of in vitro oxidized low density lipoprotein

artículo científico publicado en 1995

Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries

artículo científico publicado en 1993

Impact of endotoxin challenge in obese pigs

artículo científico publicado en 2014

Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression

artículo científico publicado en 2005

Influence of High-Fat Feeding on Both Naive and Antigen-Experienced T-Cell Immune Response in DO10.11 Mice

artículo científico publicado en 2006

Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans.

artículo científico publicado en 2016

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

article

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits

artículo científico publicado en 2012

Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins

artículo científico publicado en 2002

Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass

artículo científico publicado en 2016

Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.

artículo científico publicado en 2015

Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2013

Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays

artículo científico publicado en 2000

Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation

artículo científico publicado en 2002

Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors

artículo científico publicado en 2016

Modulation of the expression of human LDL-Apo B-100 epitopes by lipids and apolipoproteins

scientific article published on 01 April 1993

Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet.

artículo científico publicado en 2009

Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis

artículo científico publicado en 2003

Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine

artículo científico publicado en 2006

Normal HDL–apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy

article

Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives

artículo científico publicado en 2008

Overview of the Measurement of Lipids and Lipoproteins in Mice

PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia

artículo científico publicado en 2005

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH

article

Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate

artículo científico publicado en 2005

Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits

artículo científico publicado en 2000

Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice

artículo científico publicado en 2011

Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction

artículo científico publicado en 1995

Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.

artículo científico publicado en 2015

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

artículo científico publicado en 2001

Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver

artículo científico publicado en 2009

Roles of PPARs in NAFLD: potential therapeutic targets

artículo científico

Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice

artículo científico publicado en 2015

Sox17 regulates liver lipid metabolism and adaptation to fasting

artículo científico publicado en 2014

Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction.

artículo científico publicado en 2017

Tau deletion promotes brain insulin resistance

artículo científico publicado en 2017

The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity

artículo científico publicado en 2015

The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia

article

The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression

artículo científico publicado en 2014

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

article

Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.

artículo científico publicado en 1995

Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance

artículo científico publicado en 2017

Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver

scientific article published on 01 December 1996

p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.

artículo científico publicado en 2011

Lista de obras de Anne Tailleux

A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice

Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty

Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production

Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase

Apolipoprotein A-II, HDL metabolism and atherosclerosis

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

Bariatric surgery, lipoprotein metabolism and cardiovascular risk

Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development

Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1α pathway

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for R

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta

Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.

Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation

Endothelial Derived Vasorelaxation Is Impaired in Human APO A-I Transgenic Rabbits

Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).

HDL heterogeneity and atherosclerosis.

Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly.

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Host glucose metabolism mediates T4 and IL-7 action on Schistosoma mansoni development.

Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.

Immunological and functional properties of in vitro oxidized low density lipoprotein

Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries

Impact of endotoxin challenge in obese pigs

Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression

Influence of High-Fat Feeding on Both Naive and Antigen-Experienced T-Cell Immune Response in DO10.11 Mice

Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans.

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits

Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins

Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass

Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.

Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention

Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays

Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation

Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors

Modulation of the expression of human LDL-Apo B-100 epitopes by lipids and apolipoproteins

Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet.

Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis

Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine

Normal HDL–apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy

Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives

Overview of the Measurement of Lipids and Lipoproteins in Mice

PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH

Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate

Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits

Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice

Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction

Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver

Roles of PPARs in NAFLD: potential therapeutic targets

Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice

Sox17 regulates liver lipid metabolism and adaptation to fasting

Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction.

Tau deletion promotes brain insulin resistance

The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity

The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia

The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.

Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance

Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver

p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.